Quantitative evaluation of interim positron emission tomography in peripheral T-cell lymphoma.
Deauville scale
Interim evaluation
Peripheral T-cell lymphoma
Positron emission tomography
qPET
∆SUVmax
Journal
EJNMMI research
ISSN: 2191-219X
Titre abrégé: EJNMMI Res
Pays: Germany
ID NLM: 101560946
Informations de publication
Date de publication:
14 Sep 2021
14 Sep 2021
Historique:
received:
17
06
2021
accepted:
17
08
2021
entrez:
15
9
2021
pubmed:
16
9
2021
medline:
16
9
2021
Statut:
epublish
Résumé
Interim [ Interim scans from 43 patients with anaplastic lymphoma kinase-negative PTCL from the 'Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas' trial were re-analyzed by qPET (relating residual lymphoma-related uptake to liver uptake) and ∆SUV qPET and ∆SUV qPET and ∆SUV
Sections du résumé
BACKGROUND
BACKGROUND
Interim [
METHODS
METHODS
Interim scans from 43 patients with anaplastic lymphoma kinase-negative PTCL from the 'Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas' trial were re-analyzed by qPET (relating residual lymphoma-related uptake to liver uptake) and ∆SUV
RESULTS
RESULTS
qPET and ∆SUV
CONCLUSIONS
CONCLUSIONS
qPET and ∆SUV
Identifiants
pubmed: 34523055
doi: 10.1186/s13550-021-00827-1
pii: 10.1186/s13550-021-00827-1
pmc: PMC8440745
doi:
Types de publication
Journal Article
Langues
eng
Pagination
90Informations de copyright
© 2021. The Author(s).
Références
Blood. 2014 Sep 4;124(10):1570-7
pubmed: 25006130
J Nucl Med. 2021 Aug 1;62(8):1068-1074
pubmed: 33246974
J Clin Oncol. 2018 Jul 10;36(20):2024-2034
pubmed: 29750632
PLoS One. 2020 Apr 2;15(4):e0231027
pubmed: 32240248
J Nucl Med. 2021 Mar;62(3):338-341
pubmed: 32764122
Hematol Oncol. 2020 Aug;38(3):244-256
pubmed: 32067259
Blood. 2021 May 13;137(19):2646-2656
pubmed: 33512419
J Clin Oncol. 2017 Dec 20;35(36):4019-4026
pubmed: 29072976
Eur J Nucl Med Mol Imaging. 2014 Jul;41(7):1301-8
pubmed: 24604592
J Clin Oncol. 2014 Sep 20;32(27):3048-58
pubmed: 25113771